NEW SOLUTIONS IN THE DIAGNOSIS AND TREATMENT OF POLYCYSTIC OVARY SYNDROME IN ADOLESCENT GIRLS
Main Article Content
Abstract
The aim of the research – a study of the scientific literature in order to summarize recommendations for the diagnosis and treatment of adolescents with PCOS.
Materials and methods. The PubMed, Scopus, Web of Science, and Google scholar databases were searched for reviews, clinical trials, and observational studies on the diagnosis and treatment of PCOS in adolescent girls through November 2021.
Results. It is important to examine all adolescent girls with persistent hyperandrogenism and oligoanovulation using standard PCOS diagnostic criteria developed for adolescents, to conduct dynamic observation to make timely and correct therapeutic decisions. Lifestyle modification effectively affects the clinical manifestations of PCOS, improves the outcome of the disease. Drug therapy should be recommended on the basis of clinical recommendations for the treatment of the disease and based on the safety of use at a given age.
Conclusion. Early diagnosis, timely treatment of PCOS in adolescents are the main components for maintaining fertility and avoiding problems with the implementation of reproductive function in the future.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Adamyan LV, Makiian ZN, Glybina TM, Sibirskaia EV, Ploshkina AA. Diagnosis and management of PCOS predictors in adolescent patients. Russian Journal of Human Reproduction. 2014; 5: 52-56. Russian (Адамян Л.В., Макиян З.Н., Глыбина Т.М., Сибирская Е.В., Плошкина А.А. Предикторы синдрома поликистозных яичников у юных пациенток (обзор литературы) //Проблемы репродукции. 2014. № 5. С. 52-56)
Adamyan LV, Makiyan ZN, Glybina TM, Sibirskaya EV, Ploshkina AA. Features of diagnosis and treatment of polycystic ovary syndrome in adolescent girls (analytical review). Reproductive health of children and adolescents. 2014; 3: 16-23. Russian (Адамян Л.В., Макиян З.Н., Глыбина Т.М., Сибирская Е.В., Плошкина А.А. Особенности диагностики и лечения синдрома поликистозных яичников у девочек-подростков (аналитический обзор) //Репродуктивное здоровье детей и подростков. 2014. № 3. С. 16-23)
Bogdanova EA. Gynecology of children and adolescents. M.: MIA, 2010. P. 332-348. Russian (Богданова Е.А. Гинекология детей и подростков. М.: МИА, 2010. С. 332-348
Beglova AYu, Yelgina SI. Development of a computer program for the diagnosis of polycystic ovary syndrome in women of early reproductive age. Fundamental and Clinical Medicine. 2020; 5(1): 35-45. Russian (Беглова А.Ю., Елгина С.И. Разработка компьютерной программы диагностики синдрома поликистозных яичников у женщин раннего репродуктивного возраста //Фундаментальная и клиническая медицина. 2020. Т. 5, № 1. С. 35-45.) DOI: 10.23946/2500-0764-2020-5-1-35-45
Buyanova SN, Shchukina NA, Babunashvili EL. Biological role, therapeutic potential of bioflavonoids, vitamin D in the treatment of patients with uterine fibroids and other promising pharmacological directions. Russian Bulletin of the obstetrician-gynecologist. 2018; 18(5): 36-42. Russian (Буянова С.Н., Щукина Н.А., Бабунашвили Е.Л. Биологическая роль, терапевтический потенциал фитофлавоноидов, витамина D в лечении больных с миомой матки и другие перспективные фармакологические направления //Российский вестник акушера-гинеколога. 2018. Т. 18, № 5. С. 36-42)
Popov AA, Krasnopolsky VI, Buyanova SN, Shchukina NA. Operative gynecology: MEDpress-Inform, 2013. P. 226-231. Russian (Попов А.А., Краснопольский В.И., Буянова С.Н., Щукина Н.А. Оперативная гинекология: МедПресс-Информ, 2013. С. 226-231)
Kalugina AS, Bobrov KYu. Polycystic ovary syndrome: modern concepts and role in the problem of infertility (literature review). Reproduction problems. 2015; 21(2): 31-35. Russian (Калугина А.С., Бобров К.Ю. Синдром поликистозных яичников: современные представления и роль в проблеме бесплодия (обзор литературы) //Проблемы репродукции. 2015. Т. 21, № 2. С. 31-35)
Mazitova LP, Aslamazyan LK. Pathogenetic justification of local acne therapy in adolescence. Pediatric pharmacology. 2008; 5; 68-71. Russian (Мазитова Л.П. Асламазян Л.К. Патогенетическое обоснование местной терапии акне в подростковом возрасте //Педиатрическая фармакология. 2008. № 5. С. 68-71)
Manukhin IB, Gevorkyan MA, Kushlinsky NE. Polycystic ovary syndrome. Moscow: MIA, 2004. P. 192-196. Russian (Манухин И.Б., Геворкян М.А., Кушлинский Н.Е. Синдром поликистозных яичников. М.: МИА, 2004. С. 192-196)
Guide to Endocrine Gynecology /ed. Vikhlyaeva EM. M.: Medical Information Agency, 2006. 784 p. Russian (Руководство по эндокринной гинекологии /под ред. Вихляевой Е.М. М.: Мед. информ. агентство, 2006. 784 с.)
Manukhin IB, Gevorkyan IM, Manukhina EI. Hyperandrogenic syndromes in gynecology: GEOTAR-Media, 2020. P. 186-192. Russian (Манухин И.Б., Геворкян И.М., Манухина Е.И. Гиперандрогенные синдромы в гинекологии: ГЭОТАР-Медиа, 2020. С. 186-192)
Uvarova EV. Hormonal preparations in the practice of a pediatric gynecologist. Attending Physician. 2002; 3; 38-45. Russian (Уварова Е.В. Гормональные препараты в практике детского гинеколога //Лечащий Врач. 2002. № 3. С. 38-45)
Uvarova EV. Pediatric and adolescent gynecology. M.: Medicine, 2009. P. 249-268. Russian (Уварова Е.В. Детская и подростковая гинекология. М.: Медицина, 2009. С. 249-268)
Uvarova EV. Modern methods of correction of hyperandrogenism in adolescent girls. In: Effective pharmacotherapy in obstetrics and gynecology. 2008. P. 4-12. Russian (Уварова Е.В. Современные способы коррекции гиперандрогении у девочек-подростков. В кн.: Эффективная фармакотерапия в акушерстве и гинекологии. 2008. С. 4-12)
Shilin DE. Correction of metabolic and endocrine disorders in the treatment of hyperandrogenism in girls and girls. Pharmateca. 2010; 16: 8-12. Russian (Шилин Д.Е. Коррекция метаболических и эндокринных нарушений при лечении гиперандрогении у девочек и девушек //Фарматека. 2010. № 16. С. 8-12)
Bloomgarden ZT. American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome. Diabetes Care. 2003; 26: 1297-1303
Christensen SB, Black MH, Smith N, Martinez MM, Jacobsen SJ, Porter AH, Koebnick C. Prevalence of polycystic ovary syndrome in adolescents. Fertil Steril. 2013; 100(2): 470-477
Codner E, Villarroel C, Eyzaguirre FC, Lopez P, Merino PM, Perez-Bravo F, et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril. 2011; 95(2): 702-706.e1-2
de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama VA, Helmerhorst FM, Stijnen T, Dekkers OM. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014; 3: CD010813
Dunaif AR, Chang J. Polycystic Ovary Syndrome: Current Controversies, from the Ovary to the Pancreas. Humana Press. 2010; 51-122
Fauser BC. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3 rd PCOS Consensus Workshop Group. Fertil Steril. 2012; 97: 28-38
Flug D, Largo RH, Prader A. Menstrual patterns in adolescent Swiss girls: a longitudinal study. Ann Hum Biol. 2010; 11(6): 495-508
Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility. Lippincott Williams & Wilkins. 2011. P. 495-533
Gupta D, Khan S, Islam M. et al. Myo-Inositol’s Role in Assisted Reproductive Technology: Evidence for Improving the Quality of Oocytes and Embryos in Patients With Polycystic Ovary Syndrome. Cureus. 2020; 12(5): e8079. DOI: 10.7759/cureus.8079
Gambineri A, Patton L, Vaccina A, Cacciari M, Morselli-Labate AM, Cavazza C, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab. 2006; 91(10): 3970-3980
Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S, Norman RJ, Hart R. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod. 2011; 26(6): 1469-1477
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2003; 81: 19-25
Harborne LR, Sattar N, Norman JE, Fleming R. Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab. 2005; 90(8): 4593-4598
Hart R, Doherty DA, Norman RJ, Franks S, Dickinson JE, Hickey M, Sloboda DM. Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril. 2010; 94(3): 1118-1121
Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab. 2008; 93(11): 4299-4306
Ibanez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, et al. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Hormone Res Paed. 2017; 88(6): 371-395
Iliodromiti S, Kelsey TW, Anderson RA, Nelson SM. Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data. J Clin Endocrinol Metab. 2013; 98(8): 3332-3340
Kelsey TW, Dodwell SK, Wilkinson AG, Greve T, Andersen CY, Anderson RA, Wallace WH. Ovarian volume throughout life: a validated normative model. PLoS One. 2013; 8(9): e71465
Karr B., Blaquell R., Aziz R. Manual on Reprodactive Medicine. Transl. from English under the gen. ed. I.V. Kuznetsova. Moscow: Practika; 2015
Li L, Feng Q, Ye M, He Y, Yao A, Shi K. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis. J Obstet Gynaecol. 2017; 37(8): 1036-1047
Moran LJ, Noakes M, Clifton PM, Tomlinson L, Norman RJ. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88: 812-819
National Health and Medical Research Council. NHMRC Levels of Evidence and Grades for Recommendations for Developers of Guidelines. Canberra: NHMRC, 2009
Razzaghy-Azar M, Ghasemi F, Hallaji F, Ghasemi A, Ghasemi M. Sonographic measurement of uterus and ovaries in premenarcheal healthy girls between 6 and 13 years old: correlation with age and pubertal status. J Clin Ultrasound. 2011; 39(2): 64-73
Rudnicka E, Radowicki S, Suchta K. Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight. Gynecol Endocrinol. 2016; 32(11): 931-935
Stener-Victorin E, Holm G, Labrie F, Nilsson L, Janson PO, Ohlsson C. Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome? J Clin Endocrinol Metab. 2014; 95(2): 810-819
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. International PCOS. Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018; 33(9): 1602-1618
Teede H, Tassone EC, Piltonen T, Malhotra J, Mol BW, Pena A, et al. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: a systematic review with meta-analyses. Clin Endocrinol. 2019; 91(4): 479-489
Trent M, Austin SB, Rich M, Gordon CM. Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambul Pediatr. 2005; 5(2): 107-111
Witchel SF, Oberfield S, Rosenfield RL, Codner E, Bonny A, Ibanez L, et al. The diagnosis of polycystic ovary syndrome during adolescence. Hormone Res Paed. 2015; 83: 376-389
World Health Organization. Quick reference chart for the WHO medical eligibility criteria for contraceptive use. Geneva: WHO, 2016